Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

被引:0
作者
Venkata Avinash Chikatamarla
Satomi Okano
Peter Jenvey
Alexander Ansaldo
Matthew J. Roberts
Stuart C. Ramsay
Paul A. Thomas
David A. Pattison
机构
[1] Royal Brisbane and Women’s Hospital,Department of Nuclear Medicine and Specialised PET Services
[2] University of Queensland,Faculty of Medicine
[3] QIMR Berghofer Medical Research Institute,Statistics Unit
[4] Royal Brisbane and Women’s Hospital,Department of Medical Imaging
[5] Royal Brisbane and Women’s Hospital,Department of Urology
[6] Redcliffe Hospital,Department of Urology
[7] The University of Queensland,Centre for Clinical Research
[8] James Cook University,School of Medicine
来源
EJNMMI Research | / 11卷
关键词
[; F]PSMA-1007 PET/CT; Staging; Prostate cancer; Metastases; SUVmax; PSA; ISUP grade;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 181 条
[1]  
Rawla P(2019)Epidemiology of prostate cancer World J Oncol 10 63-89
[2]  
Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[3]  
Ferlay J(2019)Detection efficacy of (18)F-PSMA-1007 PET/CT in 251 Patients with biochemical recurrence of prostate cancer after radical prostatectomy J Nucl Med 60 362-368
[4]  
Siegel RL(2021)Diagnostic accuracy of (68)Ga-PSMA PET/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis AJR Am J Roentgenol 216 599-607
[5]  
Laversanne M(2012)[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients BJU Int 110 1666-1671
[6]  
Soerjomataram I(2021)The diagnostic role of (18)F-choline, (18)F-fluciclovine and (18)F-PSMA PET/CT in the detection of prostate cancer with biochemical recurrence: a meta-analysis Front Oncol 11 684629-369
[7]  
Jemal A(2021)Detection rate of prostate specific membrane antigen tracers for positron emission tomography/computerized tomography in prostate cancer biochemical recurrence: a systematic review and network meta-analysis J Urol 205 356-688
[8]  
Giesel FL(2020)Detection of recurrent prostate cancer with (18)F-fluciclovine PET/MRI Front Oncol 10 582092-213
[9]  
Knorr K(2017)(68)Ga or (18)F for prostate cancer imaging? J Nucl Med 58 687-532
[10]  
Spohn F(2021)Diagnostic accuracy of (18)F-PSMA-1007 PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence J Nucl Med 62 208-974